KRAS mutations

Related by string. KRAS mutation * Kras . Kra . K RAS . K ras . KRAs : mutated KRAS . non mutated KRAS . type KRAS mCRC . KRAS gene mutations . KRAS gene mutation . KRAS oncogene . KRAS BRAF / Mutations . Mutation : gene mutation . inherited mutations . gene mutations . G#D mutation . genetic mutations identical . activating mutations . spontaneous mutation * KRAS mutation status . KRAS mutations occur *

Related by context. Frequent words. (Click for all words.) 77 EGFR mutations 68 breast carcinoma 67 CYP#C# [001] 67 CYP#C# [002] 66 distant metastasis 66 estrogen receptor ER 66 HER2 negative 66 EpCAM 66 EGFR inhibitors 66 xenograft models 65 adenocarcinomas 65 poorer prognosis 65 HER2 positive metastatic breast 65 Recurrence Score 65 BRCA mutations 64 BRCA2 mutation 64 malignant lesions 64 EGFRvIII 64 PCa 64 KRAS 64 estrogen receptor negative 64 BRCA2 mutations 63 mRNA expression 63 endometrial cancers 63 CYP#D# 63 HGS ETR1 63 gefitinib 63 FOLFIRI 63 neoplastic 63 decitabine 63 XELOX 63 mycophenolate mofetil 63 HER2/neu 63 distant metastases 63 lymph node involvement 63 heterozygous 63 genotypic 62 coinfected 62 dasatinib 62 T#I mutation 62 histologically 62 ApoE4 62 prognostic factors 62 neoadjuvant chemotherapy 62 pg ml 62 polymorphisms 62 IGF 1R 62 FDG PET 62 metastatic renal cell carcinoma 62 adjuvant chemotherapy 62 JAK2 62 androgen independent 62 #q# [002] 62 azacitidine 62 androgen deprivation 61 neoadjuvant 61 clusterin 61 peripheral blood mononuclear 61 seliciclib 61 rs# [003] 61 CMV disease 61 HER-2/neu 61 serum concentrations 61 lung adenocarcinoma 61 gastrointestinal stromal tumors 61 immunohistochemical 61 tyrosine kinase inhibitors 61 ApoE 61 NSCLC 61 IFN gamma 61 mesothelin 61 mg kg dose 61 TLR3 61 Lenalidomide 61 MDM2 61 trastuzumab 61 Her2 61 cetuximab 61 chronic HBV infection 61 estrogen receptors 61 survivin 60 epithelial ovarian cancer 60 gene expression profiles 60 imetelstat 60 liver metastases 60 histologic 60 APOE4 60 osteopontin 60 PXD# 60 nelfinavir 60 EGFR 60 squamous 60 virologic failure 60 tanespimycin 60 malignant pleural mesothelioma 60 FOLFOX 60 estrogen receptor positive 60 serologic 60 hepatocellular carcinoma HCC 60 bortezomib 60 allogeneic stem cell

Back to home page